Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.
van de Loosdrecht AA, Cremers EMP, Alhan C, Duetz C, In 't Hout FEM, Visser-Wisselaar HA, Chitu DA, Verbrugge A, Cunha SM, Ossenkoppele GJ, Janssen JJWM, Klein SK, Vellenga E, Huls GA, Muus P, Langemeijer SMC, de Greef GE, Te Boekhorst PAW, Raaijmakers MHG, van Marwijk Kooy M, Legdeur MC, Wegman JJ, Deenik W, de Weerdt O, van Maanen-Lamme TM, Jobse P, van Kampen RJW, Beeker A, Wijermans PW, Biemond BJ, Tanis BC, van Esser JWJ, Schaar CG, Noordzij-Nooteboom HS, Jacobs EMG, de Graaf AO, Jongen-Lavrencic M, Stevens-Kroef MJPL, Westers TM, Jansen JH. van de Loosdrecht AA, et al. Among authors: jansen jh. Leukemia. 2024 Apr;38(4):840-850. doi: 10.1038/s41375-024-02161-6. Epub 2024 Jan 31. Leukemia. 2024. PMID: 38297135 Free PMC article. Clinical Trial.
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Emile JF, Ferry J, Fogelstrand L, Fontenay M, Germing U, Gujral S, Haferlach T, Harrison C, Hodge JC, Hu S, Jansen JH, Kanagal-Shamanna R, Kantarjian HM, Kratz CP, Li XQ, Lim MS, Loeb K, Loghavi S, Marcogliese A, Meshinchi S, Michaels P, Naresh KN, Natkunam Y, Nejati R, Ott G, Padron E, Patel KP, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Tyner J, Verstovsek S, Wang W, Wood B, Xiao W, Yeung C, Hochhaus A. Khoury JD, et al. Among authors: jansen jh. Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22. Leukemia. 2022. PMID: 35732831 Free PMC article. Review.
The DC-derived protein DC-STAMP influences differentiation of myeloid cells.
Eleveld-Trancikova D, Janssen RA, Hendriks IA, Looman MW, Moulin V, Jansen BJ, Jansen JH, Figdor CG, Adema GJ. Eleveld-Trancikova D, et al. Among authors: jansen bj, jansen jh. Leukemia. 2008 Feb;22(2):455-9. doi: 10.1038/sj.leu.2404910. Epub 2007 Aug 23. Leukemia. 2008. PMID: 17713547 No abstract available.
Increased clonal hematopoiesis in long-term survivors of pediatric hematopoietic cell transplantation.
Müskens KF, Wieringa N, van Bergen MGJM, Bense JE, Te Pas BM, de Pagter APJ, Lankester AC, Bierings MB, Neuberg DS, Haitjema S, Kremer LCM, Huls GA, Nierkens S, Jansen JH, Lindemans CA, de Graaf AO, Belderbos ME. Müskens KF, et al. Among authors: jansen jh. Blood Cancer Discov. 2025 Jan 13. doi: 10.1158/2643-3230.BCD-24-0136. Online ahead of print. Blood Cancer Discov. 2025. PMID: 39804695
High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine.
Tiso F, In 't Hout FEM, Knops R, Kroeze LI, van Rooij A, van de Loosdrecht AA, Westers TM, Langemeijer SMC, Preudhomme C, Duployez N, Fenaux P, Kosmider O, Bouscary D, de Graaf AO, Martens JHA, van der Reijden BA, Adès L, Fontenay M, Jansen JH. Tiso F, et al. Among authors: jansen jh. Hemasphere. 2025 Jan 3;9(1):e70034. doi: 10.1002/hem3.70034. eCollection 2025 Jan. Hemasphere. 2025. PMID: 39760001 Free PMC article. No abstract available.
HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia.
Arza-Apalategi S, Heuts BMH, Bergevoet SM, Meering R, Gilissen D, Jansen PWTC, Krippner-Heidenreich A, Valk PJM, Vermeulen M, Heidenreich O, Haferlach T, Jansen JH, Martens JHA, van der Reijden BA. Arza-Apalategi S, et al. Among authors: jansen jh. Leukemia. 2024 Dec 4. doi: 10.1038/s41375-024-02485-3. Online ahead of print. Leukemia. 2024. PMID: 39633068
316 results